REGN
Regeneron Pharmaceuticals, Inc.$623.54-1.31% 1D· price as of Jun 30, 8:32 PM+19.68% over 1Y
Compare:REGN
Mkt Cap
$65.4B
P/E
15.2×
Fwd P/E
11.6×
PEG
1.09
P/B
2.0×
P/S
4.4×
EV/EBITDA
13.1×
Beta
0.24
Div Yield
0.6%
Payout
8.7%
ROE
14.5%
Net Margin
29.6%
Short % Flt
3.4%
Inst. Own
92.3%
52-wk low $521.00$623.5452-wk high $821.11
+19.7% above low-24.1% from high
Seasonality — avg monthly return
Strongest Aug 8.9% · weakest Apr -4.6%Jan
+0.6
Feb
+0.5
Mar
+2.5
Apr
-4.6
May
-4.0
Jun
+2.5
Jul
+2.2
Aug
+8.9
Sep
-1.3
Oct
+1.0
Nov
+2.9
Dec
-0.9
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Regeneron Pharmaceuticals, Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
REGN — recent news
Loading headlines…
Quality scorecard
vs Biotechnology · 8 peers · percentile rank
52 / 100
Average
ROIC9.6%
29
ROE14.4%
43
Gross margin85.4%
71
Operating margin25.8%
43
FCF yield5.7%
57
Net debt / EBITDAnet cash
71
Percentile vs 8 Biotechnology peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.